12/2/2016 | BKCVHY | S&P lifts, withdraws AmSurg
|
6/20/2016 | BKCVHY | S&P: AmSurg on positive watch
|
6/16/2016 | BKCVHY | Moody’s might lower AmSurg
|
10/21/2015 | BKCVHY | Moody’s cuts AmSurg to negative
|
1/14/2015 | BKBWCVHYLM | AmSurg plans to bring leverage to 4 times following acquisition via M&A synergies
|
7/3/2014 | BKCVDDEMIGPV | Market Commentary: Quiet primary in short session closes $4.46 billion week; Verso up; funds gain $90 million
|
7/2/2014 | BKCVDDEMIGPV | Market Commentary: RJS megadeal is sole pricing, moves up; Allegiant active; Constellation firms on numbers
|
7/2/2014 | CV | AmSurg greenshoe exercise ups convertible sale to $172.5 million
|
7/2/2014 | CV | Market Commentary: Nuance, Shutterfly slip on hedge on takeout chatter; newer deals Dominion, AmSurg in trade
|
7/2/2014 | BKCVHY | S&P lifts AmSurg notes after downsizing
|
7/1/2014 | BKCVDDEMIGPV | Market Commentary: AmSurg, Jaguar, Hub, Puma deals open second half; Isle of Capri up on renewed sale talks
|
6/30/2014 | BKCVDDEMIGPV | Market Commentary: Altegrity, Ithaca Energy, New Cotai price; AmSurg, Puma slate to open pre-holiday week
|
6/30/2014 | BKCVHY | Moody’s cuts AmSurg, rates loans Ba2
|
6/27/2014 | CV | Market Commentary: Convertible primary market quiet after active week; MannKind gets Afrezza drug approval
|
6/27/2014 | CV | Market Commentary: Morning Commentary: Convertible market takes a breather after active week in the primary
|
6/26/2014 | CV | New Issue: AmSurg prices $150 million 5.25% mandatory convertibles, up 20.5%
|
6/26/2014 | CV | Market Commentary: New Dominion units trade well; older Dominion tranches also add; AmSurg offering on tap
|
6/23/2014 | CV | Market Commentary: Primary market resets with launch of four deals; secondary market puts in ‘dull’ session
|
6/23/2014 | CV | AmSurg to price $125 million mandatory convertibles to yield 5.25%-5.75%, up 17.5%-22.5%
|